Who invested in ABL Bio?
ABL Bio's investors include Korea Investment Partners, Eli Lilly, IMM Investment and DSC Investment.

South Korea · Funded startup
Funding summaryUpdated 26 Oct 2026
$18Mraised across 2 rounds since 2023, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $3.0M sold, first sale Jul 2023
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ABL Bio's investors include Korea Investment Partners, Eli Lilly, IMM Investment and DSC Investment.
ABL Bio has raised $18M across 2 rounds since 2023.
ABL Bio's most recent round was an Undisclosed round of $15M in Nov 2025.
Its most recent round, $15M in Nov 2025, is also its largest on record.
ABL Bio's first round on record, in Sept 2023, was backed by Korea Investment Partners, IMM Investment and DSC Investment.
ABL Bio's latest named round is an Undisclosed round, in Nov 2025.
ABL Bio is based in South Korea.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.